News FDA Approves Brolucizumab for Diabetic Macular Edema by Medscape • 2022/06/08 • 0 Comments Brolucizumab wins approval for diabetic macular edema but with a warning of retinal vasculitis and retinal vascular occlusion. FDA Approvals Full Story →